<code id='F04ABC83FF'></code><style id='F04ABC83FF'></style>
    • <acronym id='F04ABC83FF'></acronym>
      <center id='F04ABC83FF'><center id='F04ABC83FF'><tfoot id='F04ABC83FF'></tfoot></center><abbr id='F04ABC83FF'><dir id='F04ABC83FF'><tfoot id='F04ABC83FF'></tfoot><noframes id='F04ABC83FF'>

    • <optgroup id='F04ABC83FF'><strike id='F04ABC83FF'><sup id='F04ABC83FF'></sup></strike><code id='F04ABC83FF'></code></optgroup>
        1. <b id='F04ABC83FF'><label id='F04ABC83FF'><select id='F04ABC83FF'><dt id='F04ABC83FF'><span id='F04ABC83FF'></span></dt></select></label></b><u id='F04ABC83FF'></u>
          <i id='F04ABC83FF'><strike id='F04ABC83FF'><tt id='F04ABC83FF'><pre id='F04ABC83FF'></pre></tt></strike></i>

          leisure time

          leisure time

          author:knowledge    Page View:46843
          Richard Burr
          North Carolina Senator Richard Burr received strong support from the biotech sector. Gerry Broome/AP

          WASHINGTON — A veteran senator and champion of the biotech sector beat back an unusually strong challenge Tuesday night — thanks in large part to loyal support from the industry.

          North Carolina Senator Richard Burr, a Republican who has long protected the bioscience companies that drive his state’s economy, overcame a surprisingly robust challenge from Democratic candidate Deborah K. Ross.

          advertisement

          Burr, now finishing his second term in the Senate, serves on committees with oversight of both the Food and Drug Administration and Medicare and Medicaid. He is also chairman of the Select Committee on Intelligence.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          GSK Flovent asthma inhalers replaced by authorized generics
          GSK Flovent asthma inhalers replaced by authorized generics

          AdobeAsofJan.1,thousandsofasthmapatientsintheU.S.willnolongerbeabletogetrefillsforFlovent—oneofthemo

          read more
          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more

          The biotech scorecard for Q1: 17 stock

          RyanPierse/GettyImagesHereisSTAT’sbiotechscorecard,ourregularledgerofstock-movingbiotechevents,forth